ArticleNature genetics2018
Revisiting signatures of neutral tumor evolution in the light of complexity of cancer genomic data.
Article in Nature genetics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- An enhanced genetic model of relapsed IGH-translocated multiple myeloma evolutionary dynamics.Blood cancer journal · 2020Trial
- A new cancer progression model: From synthetic tumors to real data and back.PLoS computational biology · 2026Article
- Interpreting cancer genetics through a two-step "evolutionary cascade hypothesis": bridging neutral and selective perspectives.Journal of translational medicine · 2026Review
- Time-resolved, integrated analysis of clonally evolving genomes.PLoS genetics · 2023Article
- Single-cell phylogenies reveal changes in the evolutionary rate within cancer and healthy tissues.Cell genomics · 2023Article
- Artificial intelligence vs. evolving super-complex tumor intelligence: critical viewpoints.Frontiers in artificial intelligence · 2023Article
- Gattaca: Base-Pair Resolution Mutation Tracking for Somatic Evolution Studies using Agent-based Models.Molecular biology and evolution · 2022Article
- Clonal Evolution of Multiple Myeloma-Clinical and Diagnostic Implications.Diagnostics (Basel, Switzerland) · 2021Review
- Review
- Signatures of neutral evolution in exponentially growing tumors: A theoretical perspective.PLoS computational biology · 2021Article
- Neutral syndrome.Nature human behaviour · 2020Review
- Somatic substitution signature as an innovative tool in lung cancer diagnosis.Scientific reports · 2019Article
- On measuring selection in cancer from subclonal mutation frequencies.PLoS computational biology · 2019Article
- Reply to 'Revisiting signatures of neutral tumor evolution in the light of complexity of cancer genomic data'.Nature genetics · 2018Article
Corrections and comments
- Commented on by
- Comment on
Authors and funding
2 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.